Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)
Camp4 Therapeutics' (CAMP) quarterly Other Accumulated Expenses came in at $27000.0 in Q4 2025, down 84.66% year-on-year from $176000.0 in Q4 2024, and down 84.66% quarter-over-quarter from $176000.0 in Q4 2024.
Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Camp4 Therapeutics has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $27000.0 for Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $27000.0, down 84.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $27000.0 (down 84.66% YoY), and the FY2025 annual result was $27000.0, down 84.66% from the prior year.
- Other Accumulated Expenses came in at $27000.0 for Q4 2025 at Camp4 Therapeutics, down from $176000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $369000.0 in Q3 2024 to a low of $27000.0 in Q4 2025.
- The 3-year median for Other Accumulated Expenses is $232500.0 (2023), against an average of $215250.0.
- Across the five-year window, Other Accumulated Expenses plunged 39.1% in 2024 and sank 84.66% in 2025, its largest moves.
- Camp4 Therapeutics' Other Accumulated Expenses stood at $289000.0 in 2023, then slumped by 39.1% to $176000.0 in 2024, then tumbled by 84.66% to $27000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $27000.0 (Q4 2025), $176000.0 (Q4 2024), and $369000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Dec 31, 2023 | 289,000.00 |